Susan Zeigenfuss

Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158.

W. Miller, S. Jalal, S. Piha-Paul, 2018 .

Pembrolizumab treatment of advanced cervical cancer: Updated results from the phase 2 KEYNOTE-158 study.

J. Schellens, A. Italiano, S. Piha-Paul, 2018 .

Pembrolizumab for previously treated advanced cervical squamous cell cancer: Preliminary results from the phase 2 KEYNOTE-158 study.

J. Schellens, H. Chung, A. Marabelle, 2017 .

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.

A. Italiano, S. Piha-Paul, A. Leary, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.